{"id":2034,"date":"2026-05-07T16:35:06","date_gmt":"2026-05-07T14:35:06","guid":{"rendered":"https:\/\/sites.unica.it\/pe2026\/?p=2034"},"modified":"2026-05-13T12:51:43","modified_gmt":"2026-05-13T10:51:43","slug":"fernando-cagide-fagin","status":"publish","type":"post","link":"https:\/\/sites.unica.it\/pe2026\/2026\/05\/07\/fernando-cagide-fagin\/","title":{"rendered":"Fernando Cagide-Fag\u00edn"},"content":{"rendered":"\n<hr class=\"wp-block-separator has-alpha-channel-opacity\" \/>\n\n\n\n<div class=\"wp-block-media-text is-stacked-on-mobile\" style=\"grid-template-columns:15% auto\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" decoding=\"async\" width=\"512\" height=\"512\" src=\"http:\/\/sites.unica.it\/pe2026\/files\/2025\/09\/cropped-00_Profile_Tondo-Social__Spilla_PE26_1200px.png\" alt=\"\" class=\"wp-image-312 size-full\" srcset=\"https:\/\/sites.unica.it\/pe2026\/files\/2025\/09\/cropped-00_Profile_Tondo-Social__Spilla_PE26_1200px.png 512w, https:\/\/sites.unica.it\/pe2026\/files\/2025\/09\/cropped-00_Profile_Tondo-Social__Spilla_PE26_1200px-300x300.png 300w, https:\/\/sites.unica.it\/pe2026\/files\/2025\/09\/cropped-00_Profile_Tondo-Social__Spilla_PE26_1200px-150x150.png 150w, https:\/\/sites.unica.it\/pe2026\/files\/2025\/09\/cropped-00_Profile_Tondo-Social__Spilla_PE26_1200px-270x270.png 270w, https:\/\/sites.unica.it\/pe2026\/files\/2025\/09\/cropped-00_Profile_Tondo-Social__Spilla_PE26_1200px-192x192.png 192w, https:\/\/sites.unica.it\/pe2026\/files\/2025\/09\/cropped-00_Profile_Tondo-Social__Spilla_PE26_1200px-180x180.png 180w, https:\/\/sites.unica.it\/pe2026\/files\/2025\/09\/cropped-00_Profile_Tondo-Social__Spilla_PE26_1200px-32x32.png 32w\" sizes=\"auto, (max-width: 512px) 100vw, 512px\" \/><\/figure><div class=\"wp-block-media-text__content\">\n<p class=\"has-text-align-left\"><strong>PC6 &#8211; Fernando Cagide-Fag\u00edn<\/strong><\/p>\n\n\n\n<p class=\"has-text-align-left\">RISE-Health, Department of Biomedicine, Pharmacology and Therapeutics Unit, Faculty of Medicine, University of Porto, Porto, Portugal<\/p>\n\n\n\n<p class=\"has-text-align-left\"><strong><a href=\"https:\/\/orcid.org\/0000-0001-9410-6874\" target=\"_blank\" rel=\"noreferrer noopener\">ORCID<\/a><\/strong><br><strong>fernando.fagin@med.up.pt<\/strong><\/p>\n<\/div><\/div>\n\n\n\n<figure class=\"wp-block-table\"><div class=\"table-responsive\"><table class=\"table  table-striped table-bordered table-hover\"  class=\"has-fixed-layout\"><tbody><tr><td><strong>Hydroxypyridin-4-one-based ligands as multifunctional therapeutics for neurodegenerative diseases<\/strong><\/td><\/tr><tr><td><em>Fernando Cagide<em><sup>1<\/sup><\/em><\/em>,<em> Carla Lima<sup>2<\/sup>, Sofia Benfeito<sup>1<\/sup>, Daniel Chavarria<sup>1<\/sup>, Lisa Sequeira<sup>1<\/sup>, B\u00e1rbara Albuquerque<sup>1<\/sup>, Paula Serr\u00e3o<sup>1<\/sup>, Patr\u00edcio Soares-da-Silva<sup>1<\/sup><sub>,<\/sub> Fernanda Borges<sup>1,2<\/sup><\/em><br><br><em><sup>1<\/sup><\/em> RISE-Health, Department of Biomedicine, Pharmacology and Therapeutics Unit, Faculty of Medicine, University of Porto, Alameda Prof. Hern\u00e2ni Monteiro, 4200-319 Porto, Portugal<br><em><sup>2<\/sup><\/em> RISE-Health, Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Rua do Campo Alegre s\/n, 4169-007 Porto, Portugal<\/td><\/tr><tr><td><strong>Abstract<\/strong><br>Neurodegenerative disorders are complex, multifactorial diseases driven by interconnected pathological processes, including neurotransmitter imbalance, oxidative stress, mitochondrial dysfunction, and metal dyshomeostasis. In Parkinson\u2019s disease (PD), dopamine depletion and iron accumulation are two closely linked hallmarks that contribute to disease progression. Catechol-O-methyltransferase (COMT) plays a central role in dopamine degradation, and its inhibition is a validated therapeutic strategy for PD. However, current COMT inhibitors such as tolcapone, entacapone, and opicapone are limited by hepatotoxicity and poor brain penetration. Their activity depends on a nitrocatechol motif that coordinates the enzyme\u2019s magnesium cofactor, but the nitro group is also associated with toxicity, underscoring the need for safer alternatives.<br>Here, we explore multitarget-directed ligands (MTDLs) as a strategy to address these converging pathological mechanisms. MTDLs are designed to combine multiple pharmacophores within a single chemical entity to simultaneously modulate dopamine dysregulation and iron-induced oxidative stress. Building on our previously identified brain-penetrant and selective COMT inhibitor (compound 9), we designed and synthesized a small library of hydroxypyridin-4-one-based derivatives incorporating iron-chelating motifs. The compounds were evaluated for COMT inhibition, metal-binding selectivity, and cytotoxicity. Several derivatives showed selective COMT inhibition, preferential binding of Cu(II) over Fe(II) and Mg(II), and no cytotoxicity at 25 \u00b5M. The results obtained so far will be presented in this communication.<\/td><\/tr><tr><td><strong>References \u00a0<\/strong><br>[1] Spahr, L.; Rubbia-Brandt, L.; Burkhard, P.R.; Assal, F.; Hadengue, A. <em>Dig. Dis. Sci. <\/em><strong>2000<\/strong>, 45 (9):1881-1884.<br>[2] GParashos, S.A., Wielinski, C.L.; Kern, J.A. <em>Clin. Neuropharmacol. <\/em>2004, 27 (3), 119-123. <br>[3] Robinson, R.G.; Smith, S.M.; et al. <em>ACS Chem. Neurosci<\/em>. <strong>2012<\/strong>, 3 (2), 129-140.<br><br><strong>Acknowledgments: <\/strong>This work was funded by FEDER funds through the Operational Program Competitiveness Factors COMPETE and national funds by the FCT-Foundation for Science and Technology under research grants for RISE-Health (UID\/06397\/2025,) and RESTORE\u00a0(COMPETE2030-FEDER-00776500 and 2023.17955.ICDT). This work was also funded by project IMPULSE and services of EU-OPENSCREEN (Horizon Europe: 101132028; DOI: 10.3030\/101132028). C.L. (UI\/BD\/154557\/2023) and B.A (2025.00893.BD) grant and D.C. (2024.07926.CEECIND) and S.B. (2023.06106.CEECIND\/CP2833\/CT0003) contracts were also supported by FCT and FEDER\/COMPETE funds.<\/td><\/tr><\/tbody><\/table><\/div><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>PC6 &#8211; Fernando Cagide-Fag\u00edn RISE-Health, Department of Biomedicine, Pharmacology and Therapeutics Unit, Faculty of Medicine, University of Porto, Porto, Portugal ORCIDfernando.fagin@med.up.pt Hydroxypyridin-4-one-based ligands as multifunctional therapeutics for neurodegenerative diseases Fernando Cagide1, Carla Lima2, Sofia Benfeito1, Daniel [&hellip;]<\/p>\n","protected":false},"author":10371,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2034","post","type-post","status-publish","format-standard","hentry","category-senza-categoria"],"_links":{"self":[{"href":"https:\/\/sites.unica.it\/pe2026\/wp-json\/wp\/v2\/posts\/2034","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sites.unica.it\/pe2026\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sites.unica.it\/pe2026\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sites.unica.it\/pe2026\/wp-json\/wp\/v2\/users\/10371"}],"replies":[{"embeddable":true,"href":"https:\/\/sites.unica.it\/pe2026\/wp-json\/wp\/v2\/comments?post=2034"}],"version-history":[{"count":7,"href":"https:\/\/sites.unica.it\/pe2026\/wp-json\/wp\/v2\/posts\/2034\/revisions"}],"predecessor-version":[{"id":2482,"href":"https:\/\/sites.unica.it\/pe2026\/wp-json\/wp\/v2\/posts\/2034\/revisions\/2482"}],"wp:attachment":[{"href":"https:\/\/sites.unica.it\/pe2026\/wp-json\/wp\/v2\/media?parent=2034"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sites.unica.it\/pe2026\/wp-json\/wp\/v2\/categories?post=2034"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sites.unica.it\/pe2026\/wp-json\/wp\/v2\/tags?post=2034"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}